跳至主要内容
临床试验/NCT01410006
NCT01410006已完成不适用

Neurofibromatosis Type 1 Patient Registry

Washington University School of Medicine1 个研究点 分布在 1 个国家目标入组 2,391 人开始时间: 2011年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
2,391
试验地点
1
主要终点
Neurofibromatosis Type 1

研究概览

简要总结

The Neurofibromatosis Type 1 (NF1) Patient Registry Initiative (NPRI) is a web-based registry that asks participants to fill out a 30-minute online questionnaire to collect information about the spectrum of medical and social problems experienced by children and adults with NF1. The information gained from your participation may one day help doctors develop personalized treatments for individuals living with NF1.

We are currently enrolling individuals with NF1 who either (1) HAVE previously been diagnosed with a brain tumor younger than 18 years or (2) HAVE NEVER had a brain tumor. Please note: there is no therapy associated with this study. Individuals may participate in the registry by going to https://nf1registry.wustl.edu/

研究设计

研究类型
Observational
观察模型
Other
时间视角
Other

入排标准

性别
All
接受健康志愿者

入选标准

  • Individuals diagnosed by a healthcare provider with Neurofibromatosis Type 1

排除标准

  • Individuals without a healthcare provider diagnosis of Neurofibromatosis Type 1

结局指标

主要结局

Neurofibromatosis Type 1

时间窗: ongoing

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Neurofibromatosis Type 1 Patient Registry | 临床试验